Stockscreener 앱 받기
0.24
1.72%
-0.0042
전일 마감가:
$0.2442
열려 있는:
$0.239
하루 거래량:
69,885
Relative Volume:
0.20
시가총액:
$4.28M
수익:
$10.34M
순이익/손실:
$-3.09M
주가수익비율:
-
EPS:
-
순현금흐름:
$-736.20K
1주 성능:
-20.00%
1개월 성능:
-36.00%
6개월 성능:
-53.85%
1년 성능:
+0.00%
1일 변동 폭
$0.2315
$0.24
1주일 범위
$0.2313
$0.31
52주 변동 폭
$0.2313
$3.39
Bionexus Gene Lab Corp Stock (BGLC) Company Profile
명칭
Bionexus Gene Lab Corp
전화
1-307-241-6898
주소
10-2 TOWER B, VERTICAL BUSINESS SUITE,, KUALA LUMPUR
BGLC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BGLC
BioNexus Gene Lab Corp Common stock
|
1.14 | 201.51M | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
21.49 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.14 | 315.71M | 2.07B | -1.42B | -1.37B | -0.1344 |
|
SHMD
Schmid Group N V
|
2.32 | 99.04M | 0 | 0 | 0 | 0.00 |
|
JUNE
Dhandho Junoon Etf
|
4.72 | 60.87M | 0 | 0 | 0 | 0.00 |
|
DAVEW
Dave Inc
|
0.155 | 0 | 0 | 0 | 0 | 0.00 |
Bionexus Gene Lab Corp 주식(BGLC)의 최신 뉴스
BGLC stock touches 52-week low at $0.28 amid sharp annual decline By Investing.com - Investing.com South Africa
BGLC stock touches 52-week low at $0.28 amid sharp annual decline - Investing.com Nigeria
BioNexus Gene Lab Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
BioNexus Gene Lab Corp (BGLC) Quarterly 10-Q Report - Quartzy
BioNexus Gene Lab stock hits 52-week low at $0.32 By Investing.com - Investing.com Canada
BioNexus Gene Lab stock hits 52-week low at $0.32 - Investing.com
BioNexus Gene Lab faces Nasdaq delisting over price rule - Investing.com India
BioNexus Gene Lab faces Nasdaq delisting over price rule By Investing.com - Investing.com Nigeria
BioNexus Gene Lab Faces Delisting and Leadership Changes - TipRanks
BioNexus Gene Lab announces board resignations By Investing.com - Investing.com Australia
BioNexus Gene Lab announces board resignations - Investing.com India
BioNexus Gene Lab faces vote impact from alleged proxy issues By Investing.com - Investing.com Australia
BioNexus Gene Lab faces vote impact from alleged proxy issues - Investing.com India
bionexus gene lab corp Earnings dates - RTTNews
BioNexus Gene Lab Corp. (NASDAQ:BGLC) Short Interest Update - Defense World
BioNexus Gene Lab Corporation announces entry into Biogas - GlobeNewswire
BioNexus Gene Lab Corporation announces entry into Biogas Sector via Teaming Agreement with Protech Builders Sdn. Bhd. - StockTitan
BioNexus Gene Lab Corp (BGLC) Stock: A Year of Market Fluctuations - The InvestChronicle
There is no way BioNexus Gene Lab Corp (BGLC) can keep these numbers up - SETE News
In the Green: BioNexus Gene Lab Corp (BGLC) Closes at 0.39, Up/Down 8.36 from Previous Day - The Dwinnex
BioNexus partners with Vitarray for gene detection - Investing.com
BioNexus Gene Lab Corp. Signs Strategic Outsourcing Agreement with VITARRAY Global Pte. Ltd. - Marketscreener.com
BioNexus Gene Lab Corp (BGLC) requires closer examination - US Post News
Bionexus Gene Lab in MOU with Shenzhen Rongguang Group for cancer screening - TipRanks
BioNexus Gene Lab Corp. Signs Strategic Partnership MOU with Shenzhen Rongguang Group to Advance Cancer Screening, Precision Medicine, and Preventative Healthcare Solutions - GlobeNewswire
Closing Figures: BioNexus Gene Lab Corp (BGLC)’s Positive Finish at 0.36, Up 2.48 - The Dwinnex
BioNexus Gene Lab Corp (BGLC) Stock: 52-Week Performance Insights and Trading Volume - The InvestChronicle
BioNexus subsidiary invests in color paste production By Investing.com - Investing.com India
Bionexus Gene Lab’s Chemrex invests RM 2M to begin color paste production - TipRanks
BioNexus Gene Lab Corp Announces New Business Developments for Subsidiary Chemrex with Investment in High-Quality Color Paste Production - StockTitan
BioNexus Gene Lab Corp revises stockholder quorum requirement - Investing.com India
How did BioNexus Gene Lab Corp (BGLC) fare last session? - US Post News
An analyst sees good growth prospects for BioNexus Gene Lab Corp (BGLC) - SETE News
BioNexus Receives Government Backing for Healthcare Tech - TipRanks
BioNexus and MyCIF invest in Malaysian healthcare tech By Investing.com - Investing.com Australia
BioNexus Gene Lab Corp. Announces Successful Securities Commission of Malaysia (MyCIF) Co-Investment in Ascension Innovation Sdn Bhd - Yahoo Finance UK
BioNexus Gene Lab Corp (BGLC)’s Market Momentum: Closing Strong at 0.44, Up 4.05 - The Dwinnex
BioNexus Gene Lab’s Strategic Investment in AI Healthcare - TipRanks
BioNexus Gene Lab Corp. Completes Strategic RM 1 Million Investment in Ascension Innovation Sdn Bhd - Marketscreener.com
Ascension Innovation raises RM1.7m funding - The Malaysian Reserve
BioNexus Gene Lab Second Quarter 2024 Earnings: US$0.005 loss per share (vs US$0.018 loss in 2Q 2023) - Yahoo Finance
Ascension Innovation Becomes First ECF Issuer To Secure MyCIF Environmental & Social Impact Fund - BusinessToday
Reviewing Exagen (NASDAQ:XGN) and BioNexus Gene Lab (NASDAQ:BGLC) - Defense World
Bionexus Gene Lab Corp (BGLC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.28%
0.54%
자본화:
|
볼륨(24시간):